QUINAPRIL

Quinapril Adverse Events Reported to the FDA Over Time

How are Quinapril adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Quinapril, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Quinapril is flagged as the suspect drug causing the adverse event.

Most Common Quinapril Adverse Events Reported to the FDA

What are the most common Quinapril adverse events reported to the FDA?

Drug Ineffective	52 (1.83%)
Dizziness	48 (1.69%)
Dyspnoea	45 (1.58%)
Headache	40 (1.41%)
Diarrhoea	35 (1.23%)
Blood Pressure Increased	34 (1.2%)
Nausea	33 (1.16%)
Hypertensive Emergency	32 (1.12%)
Cough	30 (1.05%)
Chest Pain	28 (.98%)
Hypertension	28 (.98%)
	Show More
Oedema Peripheral	28 (.98%)
Hypotension	27 (.95%)
Malaise	27 (.95%)
Blood Pressure Inadequately Control...	26 (.91%)
Hyperkalaemia	26 (.91%)
Renal Failure Acute	25 (.88%)
Death	23 (.81%)
Hypersensitivity	23 (.81%)
Blood Glucose Increased	22 (.77%)
Drug Interaction	22 (.77%)
Asthenia	21 (.74%)
Confusional State	21 (.74%)
Hyperhidrosis	20 (.7%)
Swollen Tongue	19 (.67%)
Angioedema	18 (.63%)
Cardiac Arrest	18 (.63%)
Erythema	18 (.63%)
Gait Disturbance	17 (.6%)
Myalgia	17 (.6%)
Abdominal Discomfort	16 (.56%)
Completed Suicide	16 (.56%)
Convulsion	16 (.56%)
Feeling Abnormal	16 (.56%)
Pancytopenia	16 (.56%)
Tachycardia	16 (.56%)
Anaemia	15 (.53%)
Somnolence	15 (.53%)
Blood Creatinine Increased	14 (.49%)
Condition Aggravated	14 (.49%)
Dehydration	14 (.49%)
Lip Swelling	14 (.49%)
Pain	14 (.49%)
Vomiting	14 (.49%)
Red Blood Cell Count Decreased	13 (.46%)
Respiratory Arrest	13 (.46%)
Agitation	12 (.42%)
Eye Irritation	12 (.42%)
Fall	12 (.42%)
Flushing	12 (.42%)
Haematocrit Decreased	12 (.42%)
Haemoglobin Decreased	12 (.42%)
Orthostatic Hypotension	12 (.42%)
Overdose	12 (.42%)
Pruritus	12 (.42%)
Rhabdomyolysis	12 (.42%)
Swelling Face	12 (.42%)
Therapeutic Response Unexpected Wit...	12 (.42%)
Blood Pressure Decreased	11 (.39%)
Cardiotoxicity	11 (.39%)
Dysuria	11 (.39%)
Loss Of Consciousness	11 (.39%)
Pharyngeal Oedema	11 (.39%)
Rash Erythematous	11 (.39%)
Syncope	11 (.39%)
Weight Decreased	11 (.39%)
Atrial Fibrillation	10 (.35%)
Atrioventricular Block Complete	10 (.35%)
Cerebrovascular Accident	10 (.35%)
Electrocardiogram Qrs Complex Prolo...	10 (.35%)
Fatigue	10 (.35%)
Multiple Drug Overdose	10 (.35%)
Renal Failure Chronic	10 (.35%)
Urine Flow Decreased	10 (.35%)
Weight Increased	10 (.35%)
Bradycardia	9 (.32%)
Cardiac Murmur	9 (.32%)
Cardiogenic Shock	9 (.32%)
Drug Hypersensitivity	9 (.32%)
Medication Residue	9 (.32%)
Mydriasis	9 (.32%)
Pain In Extremity	9 (.32%)
Rash	9 (.32%)
Tinnitus	9 (.32%)
Blood Magnesium Increased	8 (.28%)
Blood Urea Increased	8 (.28%)
Coronary Arterial Stent Insertion	8 (.28%)
Decreased Appetite	8 (.28%)
Drug Effect Decreased	8 (.28%)
Dysgeusia	8 (.28%)
High Density Lipoprotein Decreased	8 (.28%)
Hypokalaemia	8 (.28%)
Hyponatraemia	8 (.28%)
Low Density Lipoprotein Increased	8 (.28%)
Poisoning Deliberate	8 (.28%)
Red Blood Cell Count Increased	8 (.28%)
Subileus	8 (.28%)
Total Cholesterol/hdl Ratio Decreas...	8 (.28%)
Bladder Discomfort	7 (.25%)
Blood Cholesterol Increased	7 (.25%)
Blood Uric Acid Increased	7 (.25%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Quinapril, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Quinapril is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Quinapril

What are the most common Quinapril adverse events reported to the FDA?

Neurological	138 (4.85%)
Respiratory	120 (4.22%)
Cardiac Arrhythmias	103 (3.62%)
Therapeutic And Nontherapeutic Effe...	102 (3.59%)
Epidermal And Dermal Conditions	100 (3.51%)
Gastrointestinal Signs	97 (3.41%)
Hematology Investigations	96 (3.37%)
Cardiac And Vascular Investigations	94 (3.3%)
Decreased And Nonspecific Blood Pre...	74 (2.6%)
Electrolyte And Fluid Balance Condi...	71 (2.5%)
Vascular Hypertensive	64 (2.25%)
	Show More
Renal Disorders	63 (2.21%)
Urinary Tract Signs	53 (1.86%)
Medication Errors	50 (1.76%)
Metabolic, Nutritional And Blood Ga...	46 (1.62%)
Muscle	42 (1.48%)
Headaches	40 (1.41%)
Allergic Conditions	39 (1.37%)
Gastrointestinal Motility And Defec...	39 (1.37%)
Infections - Pathogen Unspecified	39 (1.37%)
Hepatic And Hepatobiliary	38 (1.34%)
Renal And Urinary Tract Investigati...	37 (1.3%)
Anemias Nonhemolytic And Marrow Dep...	36 (1.27%)
Lipid Analyses	32 (1.12%)
Water, Electrolyte And Mineral	31 (1.09%)
Injuries	30 (1.05%)
Coronary Artery	28 (.98%)
Deliria	27 (.95%)
Skin Appendage Conditions	27 (.95%)
Anxiety Disorders	26 (.91%)
Cardiac Disorder Signs	26 (.91%)
Angiedema And Urticaria	25 (.88%)
Fatal Outcomes	24 (.84%)
Heart Failures	24 (.84%)
Physical Examination Topics	24 (.84%)
Product Quality Issues	24 (.84%)
Chemical Injury And Poisoning	23 (.81%)
Hepatobiliary	23 (.81%)
Upper Respiratory Tract Disorders	23 (.81%)
Central Nervous System Vascular	22 (.77%)
Lower Respiratory Tract Disorders	20 (.7%)
Tongue Conditions	20 (.7%)
Seizures	19 (.67%)
Vascular	19 (.67%)
Appetite And General Nutritional	18 (.63%)
Oral Soft Tissue Conditions	18 (.63%)
Suicidal And Self-injurious Behavio...	18 (.63%)
Lifestyle Issues	16 (.56%)
Musculoskeletal And Connective Tiss...	16 (.56%)
Glucose Metabolism Disorders	14 (.49%)
Mental Impairment	14 (.49%)
Ocular Infections, Irritations And ...	14 (.49%)
Cardiac Valve	13 (.46%)
Myocardial	13 (.46%)
Nephropathies	13 (.46%)
Ocular Neuromuscular	13 (.46%)
Acid-base	11 (.39%)
Inner Ear And Viiith Cranial Nerve	11 (.39%)
Movement Disorders	10 (.35%)
Vascular Hemorrhagic	10 (.35%)
Eye	9 (.32%)
Platelet	9 (.32%)
Vascular Therapeutic Procedures	9 (.32%)
Demyelinating	8 (.28%)
Gastrointestinal Conditions	8 (.28%)
Gastrointestinal Stenosis And Obstr...	8 (.28%)
Sleep Disorders	8 (.28%)
Exocrine Pancreas Conditions	7 (.25%)
Pleural	7 (.25%)
Pulmonary Vascular	7 (.25%)
White Blood Cell	7 (.25%)
Bacterial Infectious	6 (.21%)
Body Temperature Conditions	6 (.21%)
Bronchial Disorders	6 (.21%)
Enzyme	6 (.21%)
Prostatic Disorders	6 (.21%)
Protein And Chemistry Analyses	6 (.21%)
Skin Vascular Abnormalities	6 (.21%)
Arteriosclerosis, Stenosis, Vascula...	5 (.18%)
Bone And Joint Injuries	5 (.18%)
Bone Disorders	5 (.18%)
Depressed Mood Disorders	5 (.18%)
Gastrointestinal Inflammatory Condi...	5 (.18%)
Gastrointestinal Ulceration And Per...	5 (.18%)
Joint	5 (.18%)
Malabsorption Conditions	5 (.18%)
Psychiatric	5 (.18%)
Psychiatric And Behavioural Symptom...	5 (.18%)
Gastrointestinal Therapeutic Proced...	4 (.14%)
Investigations, Imaging And Histopa...	4 (.14%)
Vision	4 (.14%)
Adrenal Gland	3 (.11%)
Coagulopathies And Bleeding Diathes...	3 (.11%)
Encephalopathies	3 (.11%)
Endocrine Investigations	3 (.11%)
Family Issues	3 (.11%)
Gastrointestinal	3 (.11%)
Gastrointestinal Hemorrhages	3 (.11%)
Gastrointestinal Vascular Condition...	3 (.11%)
Hematological And Lymphoid Tissue T...	3 (.11%)
Hemolyses And Related Conditions	3 (.11%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Quinapril, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Quinapril is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.